News

17 Dec 2014

Spain will become a full member of ELIXIR, the European bioinformatics infrastructure created to optimise biological data obtained from life sciences research.

10 Dec 2014

Malaria is one of the most serious health problems worldwide, registering 200 million clinical cases and more than 600,000 attributable deaths per year, according to information from the World Heal

9 Dec 2014

The European Commission has awarded the Institute for Research in Biomedicine (IRB Barcelona) the HR Excellence in

Media mentions

12 Dec 2014

New compounds that eliminate malaria in mice

TV3 - TN Migdia/ 3/24

Coinciding with the announcement by the WHO about a 50% decrease in number of cases of malaria, TV3 also explains IRB’s discovery of compounds that eliminate malaria in mice. ICREA researcher Lluís Ribas de Pouplana further explains that the treated mice developed an immune memory that protects against future infections.

12 Dec 2014

A project for Friedreich’s Ataxia

La Sexta

“La Sexta Columna” television programme has broadcasted a report about the initiative taken by families with relatives that suffer from Friedreich’s Ataxia, a rare illness with no cure. Joined in an association called Genefa, these families raised the funds necessary to launch a research project – involving IRB Barcelona - to find a treatment.

11 Dec 2014

Spanish scientists use a new molecule to cure malaria in mice

Cadena Ser

Cadena Ser radio, like other national and international media, has reported on the results obtained by Lluís Ribas’s team on new borrelidin-based compounds to combat the malaria-causing parasite Plasmodium. This study, published in the PNAS journal, was performed in mice, and showed that the compounds were 100% effective.

Photo gallery

Contact

Sònia Armengou
Media Relations Officer
Tel: +34 93 40 37255

Quick facts about IRB

Quick facts

IRB Barcelona upholds the importance of working on the alignment between its policies/practices and The European Charter of Researchers and The Code of Conduct adopted by European Commission. Click here for more information.

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.